A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy
Medullary thyroid carcinoma (MTC) accounts for 1-2% of all thyroid cancers. The clinical course of metastatic disease can be indolent. Our aim was to characterize the natural history of disease to evaluate the...
Thyroid Research 2017 10:6
Published on: 19 September 2017